Roche’s Susvimo, for `wet’ age-related macular degeneration (nAMD) approved
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
Subscribe To Our Newsletter & Stay Updated